| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.67B | +21.3% |
| R&D Expense | $166.0M | -15.7% |
| SG&A Expense | $382.0M | -13.6% |
| Pre-tax Income | $11.34B | +147.8% |
| Income Tax | $4.60B | +229.0% |
| Net Income | $7.08B | +111.6% |
| EPS (Basic) | $6.41 | +119.5% |
| EPS (Diluted) | $6.39 | +118.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.65B | +111.3% |
| Short-term Investments | $594.0M | +2728.6% |
| Accounts Receivable | $1.07B | +1.0% |
| Current Assets | $13.07B | +6.4% |
| Total Assets | $57.12B | +1.4% |
| Current Liabilities | $5.71B | -24.3% |
| Long-term Debt | $5.12B | -39.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.33B | +62.4% |
| Investing Cash Flow | $606.0M | +122.4% |
| Financing Cash Flow | -$7.04B | -138.4% |
| Total Liabilities |
| $23.08B |
| -12.0% |
| Stockholders' Equity | $33.87B | +13.2% |